Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab. uri icon

authors

  • Hotchkiss, Richard S
  • Park, Pauline K
  • Donnino, Michael W
  • Tidswell, Mark
  • Mayr, Florian B
  • Angus, Derek C
  • Coopersmith, Craig M
  • Moldawer, Lyle L
  • Catlett, Ian M
  • Girgis, Ihab G
  • Ye, June
  • Colston, Elizabeth
  • Grasela, Dennis M
  • Yende, Sachin
  • Crouser, Elliott D
  • Martin, Greg S
  • Albertson, Timothy
  • Bartz, Raquel R
  • Scott Brakenridge, MD
  • Delano, Matthew J

publication date

  • January 1, 2019